Monday , June 26 2017
Breaking News
Home / Business / Strides Shasun completes USFDA inspection at Bangalore facility with 3 observations

Strides Shasun completes USFDA inspection at Bangalore facility with 3 observations

Strides Shasun has completed the United States Food & Drug Administration (USFDA) inspection at its Bangalore facility. The company has been issued a Form 483 with 3 observations. None of these observations relate to data integrity and quality control. The company will address these observations comprehensively.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.

About editor

Leave a Reply

Your email address will not be published. Required fields are marked *

*